About Monte Rosa Therapeutics, Inc. 
Monte Rosa Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 33 Schemes (30.82%)
Foreign Institutions
Held by 55 Foreign Institutions (4.12%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
23 Million
(Quarterly Results - Jun 2025)
Net Profit:
-12 Million
Pharmaceuticals & Biotechnology
USD 296 Million (Micro Cap)
50.00
NA
0.00%
-1.07
9.02%
1.11






